TipRanks
MedCap AB (DE:61MA)
FRANKFURT:61MA
Germany Market
61MA
MedCap AB
RESEARCH TOOLSreports

MedCap AB (61MA) Ratios

1 Followers

MedCap AB Ratios

DE:61MA's free cash flow for Q2 2026 was kr0.60. For the 2026 fiscal year, DE:61MA's free cash flow was decreased by kr and operating cash flow was kr0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.86 2.01 2.77 2.23 2.46
Quick Ratio
 1.32 1.46 1.96 1.42 1.92
Cash Ratio
 0.52 0.75 1.12 0.55 0.78
Solvency Ratio
 0.35 0.33 0.46 0.43 0.33
Operating Cash Flow Ratio
 0.71 0.69 1.09 0.66 0.28
Short-Term Operating Cash Flow Coverage
 8.93 5.78 14.29 5.43 0.97
Net Current Asset Value
kr -168.30Mkr -155.70Mkr 214.20Mkr 130.10Mkr 171.20M
Leverage Ratios
Debt-to-Assets Ratio
 0.16 0.19 0.18 0.16 0.24
Debt-to-Equity Ratio
 0.29 0.33 0.28 0.26 0.40
Debt-to-Capital Ratio
 0.22 0.25 0.22 0.20 0.28
Long-Term Debt-to-Capital Ratio
 0.09 0.10 0.04 0.07 0.10
Financial Leverage Ratio
 1.75 1.79 1.55 1.62 1.67
Debt Service Coverage Ratio
 5.00 4.47 7.77 5.07 1.94
Interest Coverage Ratio
 7.00 9.53 14.33 14.58 10.42
Debt to Market Cap
 0.03 0.03 <0.01 0.02 0.06
Interest Debt Per Share
 33.82 34.33 25.44 18.69 24.07
Net Debt to EBITDA
 0.32 0.24 -0.03 0.21 0.44
Profitability Margins
Gross Profit Margin
38.31%15.23%58.51%58.36%41.61%
EBIT Margin
15.85%15.20%15.53%14.99%15.15%
EBITDA Margin
23.67%22.48%21.92%21.54%21.35%
Operating Profit Margin
15.15%14.24%15.07%14.33%15.38%
Pretax Profit Margin
13.91%13.71%14.48%14.00%13.68%
Net Profit Margin
10.68%10.43%11.48%10.85%10.58%
Continuous Operations Profit Margin
10.70%10.47%11.58%10.87%10.62%
Net Income Per EBT
76.74%76.06%79.28%77.46%77.37%
EBT Per EBIT
91.86%96.27%96.07%97.71%88.94%
Return on Assets (ROA)
8.67%8.43%10.41%10.36%8.23%
Return on Equity (ROE)
16.15%15.14%16.18%16.83%13.73%
Return on Capital Employed (ROCE)
15.33%14.22%16.40%17.25%15.16%
Return on Invested Capital (ROIC)
11.34%10.35%12.66%12.72%10.67%
Return on Tangible Assets
17.14%15.96%15.66%17.00%11.90%
Earnings Yield
3.14%2.67%2.33%3.45%3.67%
Efficiency Ratios
Receivables Turnover
 5.17 7.44 7.56 6.70 5.57
Payables Turnover
 3.62 5.10 10.31 7.30 8.56
Inventory Turnover
 4.66 6.58 2.79 2.39 3.99
Fixed Asset Turnover
 6.02 5.56 4.49 6.51 4.58
Asset Turnover
 0.81 0.81 0.91 0.95 0.78
Working Capital Turnover Ratio
 4.32 3.89 3.58 3.68 3.30
Cash Conversion Cycle
 48.00 32.86 143.84 157.26 114.36
Days of Sales Outstanding
 70.56 49.04 48.30 54.49 65.49
Days of Inventory Outstanding
 78.25 55.43 130.93 152.79 91.50
Days of Payables Outstanding
 100.81 71.61 35.40 50.03 42.63
Operating Cycle
 148.81 104.47 179.24 207.29 156.99
Cash Flow Ratios
Operating Cash Flow Per Share
 25.89 22.87 24.29 15.40 5.77
Free Cash Flow Per Share
 22.78 18.72 19.83 12.74 2.78
CapEx Per Share
 3.11 4.15 4.47 2.65 2.99
Free Cash Flow to Operating Cash Flow
 0.88 0.82 0.82 0.83 0.48
Dividend Paid and CapEx Coverage Ratio
 8.32 5.51 5.44 5.80 1.93
Capital Expenditure Coverage Ratio
 8.32 5.51 5.44 5.80 1.93
Operating Cash Flow Coverage Ratio
 0.85 0.71 1.01 0.87 0.25
Operating Cash Flow to Sales Ratio
 0.17 0.16 0.20 0.14 0.08
Free Cash Flow Yield
4.45%3.41%3.30%3.78%1.29%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 31.89 37.42 42.96 29.02 27.26
Price-to-Sales (P/S) Ratio
 3.40 3.90 4.93 3.15 2.88
Price-to-Book (P/B) Ratio
 4.83 5.67 6.95 4.89 3.74
Price-to-Free Cash Flow (P/FCF) Ratio
 22.46 29.33 30.31 26.48 77.81
Price-to-Operating Cash Flow Ratio
 19.75 24.01 24.74 21.92 37.49
Price-to-Earnings Growth (PEG) Ratio
 1.55 7.70 2.12 0.62 1.25
Price-to-Fair Value
 4.83 5.67 6.95 4.89 3.74
Enterprise Value Multiple
 14.67 17.60 22.46 14.83 13.95
Enterprise Value
 7.83B 8.34B 8.89B 5.07B 3.31B
EV to EBITDA
 14.67 17.60 22.46 14.83 13.95
EV to Sales
 3.47 3.96 4.92 3.19 2.98
EV to Free Cash Flow
 22.96 29.73 30.27 26.87 80.33
EV to Operating Cash Flow
 20.20 24.33 24.70 22.24 38.71
Tangible Book Value Per Share
 14.41 15.34 41.92 25.52 28.18
Shareholders’ Equity Per Share
 105.93 96.90 86.52 69.08 57.83
Tax and Other Ratios
Effective Tax Rate
 0.23 0.24 0.20 0.22 0.22
Revenue Per Share
 150.62 140.67 121.93 107.20 75.06
Net Income Per Share
 16.08 14.67 14.00 11.63 7.94
Tax Burden
 0.77 0.76 0.79 0.77 0.77
Interest Burden
 0.88 0.90 0.93 0.93 0.90
Research & Development to Revenue
 0.00 0.03 0.02 <0.01 0.03
SG&A to Revenue
 0.00 -0.02 0.39 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.30 1.13 1.32 1.32 0.50
Currency in SEK